SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Zoetis Study: Simparica Trio Tops NexGard Plus Against Resistant Heartworm

A peer-reviewed lab study funded by Zoetis found that its Simparica Trio product protected more dogs from adult heartworm than NexGard Plus when exposed to an ML-resistant heartworm isolate after six monthly doses.

ZTS